Looks like it's not flying off the shelves due to manufacturing problems. 48 million earned so far in 3 qtrs of 2018. Interesting find Timbo. I guess it shows the value of orphan drug Skype status ie if you can treat something that is currently serious and untreatable then some of the hurdles get removed. It would be interesting if their problem was with cell penetration??
https://www.fiercepharma.com/manufa...anufacturing-providing-some-out-spec-doses-to
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |